OHC Open Health Chapter Connects Malaysia with the Next Generation of Diagnostic Innovation

“Diagnostics today evolve faster than ever,” said Robert Bürger, Managing Director of OHC. “New devices are smaller, faster, and more precise. Our role is to identify promising technologies around the world and make them available here — so Malaysian healthcare providers can stay up to date without facing excessive costs or complex import barriers.”

OHC’s growing portfolio covers clinical chemistry analyzers, molecular and rapid testing systems, and performance-based diagnostic tools such as the VO₂ Master Analyzer — a portable metabolic testing device used by both medical professionals and sports scientists to measure oxygen efficiency and metabolic function. The company aims to bridge the gap between healthcare and human performance, an area where diagnostic precision increasingly supports rehabilitation, preventive medicine, and athletic health.

“Malaysia is ready for technologies that combine medical accuracy with practical application,” Bürger added. “OHC wants to help hospitals, clinics, and research centers access those tools — modern equipment that improves understanding of health and supports better outcomes for patients and professionals alike.”

OHC welcomes cooperation with hospitals, laboratories, and technology partners interested in expanding diagnostic capabilities across Malaysia and Southeast Asia.